Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04161053
PHASE3
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.
Official title: Clinical Study Evaluating the Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
Key Details
Gender
All
Age Range
20 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2018-11-01
Completion Date
2028-12
Last Updated
2019-11-13
Healthy Volunteers
No
Conditions
Interventions
DRUG
Rifaximin
Rifaximin 550 mg twice daily for 6 months
DRUG
Nitazoxanide
Nitazoxanide 500 mg twice daily for 6 months
Locations (1)
Sherief Abd-Elsalam
Tanta, Egypt